The reported incidences of such effects ... men (aged 51–65 years) who had BPH but no reported sexual dysfunction completed the 1-year study period. All participants received 5 mg/day ...
Finasteride (Proscar), which inhibits conversion of testosterone to the more potent androgen dihydrotestosterone, reduces symptoms of benign prostatic hyperplasia (BPH). Because androgens promote ...
and guidelines currently recommend that PSA values of men who undergo prostate-cancer screening while taking 5 mg finasteride daily should be doubled—although this adjustment is only accurate in ...